Drug Therapy Alternatives in the Treatment of Thyroid Cancer

ISSN： 0012-6667

Source： Drugs, Vol.55, Iss.6, 1998-06, pp. : 801-812

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Telomerase as Drug and Drug Target for the Treatment of Thyroid Cancer

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 4, Iss. 3, 2004-09 ,pp. : 253-256

Bentham Science Publishers

Access to resources Recommend Favorite

Epigenetic Drug Therapy in the Treatment of Colorectal Cancer

Current Pharmaceutical Design, Vol. 24, Iss. 23, 2018-06 ,pp. : 2701-2709

Bentham Science Publishers

Access to resources Recommend Favorite

Redifferentiation Therapy in Advanced Thyroid Cancer

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 4, Iss. 3, 2004-09 ,pp. : 175-180

Bentham Science Publishers

Access to resources Recommend Favorite

AKT: A Potential Target for Thyroid Cancer Therapy

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 4, Iss. 3, 2004-09 ,pp. : 181-185

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetic evaluation of cabozantinib for the treatment of thyroid cancer

By Karras Spyridon Pontikides Nikolaos Krassas Gerasimos E

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 4, 2013-04 ,pp. : 507-515

Informa Healthcare

Access to resources Recommend Favorite